Infectious Disease
Researchers protecting
health and prosperity
It’s the fifth anniversary of the COVID-19 pandemic and McMaster researchers are developing a better vaccine, using AI to power drug discovery, and sharing evidence-based ways to protect the health of communities and the economy.
Celebrating over 50 years of vaccinology leadership at McMaster
For over 50 years, McMaster University has been at the forefront of vaccinology, making groundbreaking contributions that have shaped the field. From pioneering critical research tools to leading innovation in next-generation inhaled vaccines, McMaster’s impact on global health is profound and far-reaching.
McMaster researchers discover new class of antibiotics
Nearly three decades after the last time a new class of antibiotics reached the market, McMaster researchers have made a breakthrough discovery that could hold the key to addressing antimicrobial resistance.
A team led by researcher Gerry Wright has identified a strong candidate to challenge some of the most drug-resistant bacteria on the planet: a new class of antibiotics called lariocidin.
The discovery could address a critical need for new antimicrobial medicines, as bacteria and other microorganisms evolve new ways to withstand existing drugs. AMR is one of the top global public health threats, and Wright says discovering new drugs is a key part of the solution.
Information Box Group
Drug discovery and biomanufacturing hub
Meet our experts
Catherine Connelly
Professor, Human Resources & Management
Tariffs expertise: • Impact on the job market • How companies can deal with economic uncertainty • Worker retraining due to changing market
Mark Loeb
Professor, Pathology & Molecular Medicine
MIRCIM 2025, Day 3
Highly pathogenic avian influenza (H5N1): An update
McMaster In the News
Want to learn more?
Sign up to receive future communications from McMaster University
